Health-related Quality of Life and Cost Effectiveness of Treatment: Components to Be Included in Clinical Decision-making

Eur Urol Oncol. 2023 Jun;6(3):349-350. doi: 10.1016/j.euo.2023.03.011. Epub 2023 Apr 7.

Authors

Cristiane Decat Bergerot¹, Julia Bonastre²

Affiliations

¹ Grupo Oncoclinicas, Centro de Cancer de Brasilia, Instituto Unity de Ensino e Pesquisa, Brasilia, Brazil. Electronic address: [email protected].
² Office of Biostatistics and Epidemiology, Université Paris-Saclay, Gustave Roussy, Villejuif, France; Inserm, Université Paris-Saclay, CESP U1018, Oncostat, Ligue Contre le Cancer, Villejuif, France.

PMID: 37032172
DOI: 10.1016/j.euo.2023.03.011

No abstract available

Publication types

Editorial
Comment

MeSH terms

Clinical Decision-Making
Cost-Benefit Analysis
Cost-Effectiveness Analysis*
Humans
Quality of Life*